Find A Doctor Find A Service Make An Appointment Talk To A Doctor

CLINICALbanner
increase text size decrease text size printer friendly



> Med Ed & Research
 
  • Pancreas Cancer

  • Pancreas Cancer

    Title(s):
    RTOG 0848. A Phase III Trial Evaluating Both Erlotinib and Chemoradiation as Adjuvant Treatment for Patients with Resected Head of Pancreas Adenocarcinoma

    Investigator(s):
    Mitchel Fromm, MD

    Contact Information:
    McDowell Cancer Research at 330-344-6348

  • Pancreas Cancer

    Title(s):
    SWOG 1115. Randomized Phase II Clinical Trial of AZD6244 Hydrogen Sulfate (NSC-748727) and MK-2206 (NSC-749607) VS mFOLFOX in Patients with Metastatic Pancreatic Cancer After Prior Chemotherapy NCI Version Date: 7/17/12

    Investigator(s):
    Esther Rehmus, MD

    Contact Information:
    McDowell Cancer Research at 330-344-6348.

  • Pancreas Cancer

    Title(s):
    RTOG 1201. A Phase II Randomized Trial of High versus Standard Intensity Local or Systemic Therapy for Unresectable Pancreatic Cancer

    Investigator(s):
    Mitchel Fromm, MD

    Contact Information:
    McDowell Cancer Research at 330-344-6348

  • Pancreas Cancer

    Title(s):
    CTSU E2211. A Randomized Phase II Study of Temozolomide or Temozolomide and Capecitabine in Patients with Advanced Pancreatic Neuroendocrine Tumors

    Investigator(s):
    Esther Rehmus, MD

    Contact Information:
    McDowell Cancer Research at 330-344-6348

  •  




    Akron General Medical Center • 1 Akron General Avenue (Formerly 400 Wabash Avenue) • Akron, OH 44307 • 330-344-6000 • 1-800-221-4601    © 2014 Akron General Health System
    Find Us on Facebook button


    This website is certified by Health On the Net Foundation. Click to verify.

      This site complies with the HONcode standard for trustworthy health information: verify here.